Labcorp Holdings, Inc. LH has announced the nationwide availability of the Lumipulse pTau-217/Beta Amyloid 42 Ratio — the first FDA-cleared blood-based in-vitro diagnostic (IVD) test to assist in ...

Global IVD Test Procedure Volumes Report 2019-2024 - ResearchAndMarkets.com December 02, 2019 07:44 AM Eastern Standard Time ...

Memory change is not always a part of normal aging, with more than 7 million adults living with Alzheimer’s disease in the ...

sphingotec launches a CE-marked point-of-care IVD assay for Proenkephalin (penKid®), the company's proprietary biomarker for real-time assessment of kidney function in critical care settings ...

Global Infectious Disease In Vitro Diagnostic (IVD) and Molecular Test Market Size, Trends and Forecasts Report 2019-2023 - ResearchAndMarkets.com December 02, 2019 12:13 PM Eastern Standard Time ...

Company also has a lung cancer test in development. Epigenomics confirmed the European launch of Epi proColon, reportedly the first CE-marked IVD blood test for detecting colorectal cancer.

IVD Test Procedure Volumes, 2020-2025 includes profiles of the top twelve IVD market competitors, looking in detail where possible at procedural volume by type.

The BioGX COVID-19, Flu A, Flu B, RSV test is marketed and sold through BioGX BV's Global Distribution Network as CE-IVD marked for In Vitro Diagnostic Use. The test is not available for sale or ...

The IVD test would be the fourth test in the family of TSO 500 products. TSO 500 is a Research Use Only comprehensive pan-cancer assay designed to identify 523 known and emerging tumor biomarkers.